Learning Objectives:

1. Understand the impact of hepatic steatosis on resident macrophages.

2. Describe the phenotypes of monocyte-derived macrophages in liver disease.

3. Recognize the clinical impact of non-alcoholic fatty liver disease.

Session date: 
02/03/2020 - 5:00pm to 6:00pm CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Joel D. Schilling, M.D., Ph.D.